Milton C. Ault III - Mar 12, 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Mar 12, 2025
Transactions value $
$68
Form type
4
Date filed
3/14/2025, 05:30 PM
Previous filing
Jan 6, 2025
Next filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $68.40 +100 +0.13% $0.68 77.4K Mar 12, 2025 By Ault Lending, LLC F1, F2
holding ALZN Common Stock 16.7K Mar 12, 2025 Direct
holding ALZN Common Stock 99.6K Mar 12, 2025 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 549 Mar 12, 2025 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.6842. The range of purchase prices on the transaction date was $0.6841 to $0.6842 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.